Skip to content

A Study Using Transcranial Magnetic Stimulation Testing to Examine the Brain Excitation and Inhibition in Eating Disorders

Evaluation of Intracortical Inhibition and Facilitation in Eating Disorders Using Paired-Pulse Transcranial Magnetic Stimulation - ED Paired-Pulse TMS Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061748
Enrollment
60
Registered
2026-06-02
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder

Interventions

None listed

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Eligible participants are Japanese individuals who meet the DSM-5-TR diagnostic criteria for an eating disorder, including anorexia nervosa, bulimia nervosa, or binge-eating disorder, and who have visited the Department of Psychiatry at Chiba University Hospital. Due to practical constraints in study implementation, recruitment will primarily focus on patients with anorexia nervosa; however, patients with bulimia nervosa or binge-eating disorder may also be enrolled if they meet the eligibility criteria. Participants must be 16 to 65 years of age at the time of informed consent. Participants may also be recruited through the Internet or posted advertisements; however, eligibility will be assessed at the time of informed consent at the Department of Psychiatry of Chiba University Hospital.

Exclusion criteria

Exclusion criteria: 1. Individuals with psychiatric disorders that preceded the onset of the eating disorder and may substantially affect the assessment of eating disorder pathology, such as schizophrenia spectrum disorders, bipolar disorder, or alcohol or substance use disorders. 2. Individuals with severe physical illnesses. 3. Individuals with a past or current history of central nervous system disorders, other than the target disease, including epilepsy or head injury associated with loss of consciousness. 4. Individuals with metal objects or devices in the head region, including cochlear implants, ferromagnetic clips, deep brain stimulation devices, or vagus nerve stimulation devices, or those with cardiac pacemakers. 5. Individuals who have not been informed of their diagnosis at the time of obtaining consent. 6. Women who are pregnant, may be pregnant, or are breastfeeding. 7. Individuals whose worsening clinical condition makes it difficult for them to fully understand the study and to decide whether to participate. 8. Individuals judged by the attending physician or study physician to be unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Intracortical inhibition and facilitation indices derived from motor evoked potentials recorded from the right first dorsal interosseous muscle using transcranial magnetic stimulation, including SICI, LICI, ICF, and cortical silent period

Secondary

MeasureTime frame
Behavioural measures assessed using response inhibition tasks, and clinical assessment measures including the severity of eating disorder symptoms

Countries

Japan

Contacts

Public ContactYusuke Sudo

Chiba University Center for Forensic Mental Health Division of Clinical Neuroscience

cfmh-jim@office.chiba-u.jp0432227171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026